Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 6

Clinical characteristics and outcome of Brucella endocarditis

Pages
1729–1733
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is necessary to screen for and recognize Brucella endocarditis cases early and to provide adequate antibiotic treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Brucella endocarditis, which is a rare condition, is the most common cause of death in human brucellosis, leading to severe cardiac complications.
📊
Key Findings & Data:Materials and methods: Presented here are 5 cases of Brucella endocarditis, all managed uniformly.
💡
Conclusion & Impact:It is necessary to screen for and recognize Brucella endocarditis cases early and to provide adequate antibiotic treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Brucella endocarditis, which is a rare condition, is the most common cause of death in human brucellosis, leading to severe cardiac complications. By collecting and analyzing clinical cases, we analyzed the clinical characteristics and outcome of Brucella endocarditis in endemic areas in China. Materials and methods: Presented here are 5 cases of Brucella endocarditis, all managed uniformly. We present the clinical, serological, and echocardiographic features; the therapeutic approach; and the follow-up of five patients with Brucella endocarditis. Results: There was a predominance of aortic involvement (4 cases) and a high incidence of left ventricular failure (5 cases). Polymerase chain reaction (PCR) testing was positive in all five patients. Diagnostic suspicion was essential in order to test blood cultures correctly, which in this series were positive in 3 patients. In the follow-up postoperative period of a minimum of 24 months, the patients suffered rare relapse in terms of either the infection or the dysfunction in terms of prosthesis after 3-month antibiotic therapy, with only one exception that died within that period. Conclusion: We should pay attention to Brucella infections and strengthen public awareness and education. It is necessary to screen for and recognize Brucella endocarditis cases early and to provide adequate antibiotic treatment.

🔖

Cite This Article

WANG, F., DU, N. (2022). Clinical characteristics and outcome of Brucella endocarditis. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 6, 1729–1733. https://ajindex.com/articles/611083

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2010; 85: 422-426
  2. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012; 59: 1968-1976
  3. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG, Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 2012; 172: 363-365
  4. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 2010; 31: 1890- 1897
  5. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison Lars, Pappas PA, Moreillon P et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463-473
  6. Valliattu J, Shuhaiber H, Kiwan Y, Araj G, Chugh T. Brucella endocarditis. Report of one case and review of the literature. J Cardiovasc Surg (Torino) 1989; 30: 782-785
  7. Al Dahouk S, Nockler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 2011; 9: 833-845
  8. Cacho JB, Aguirre PM, Hernanz A, Velasco AC. Evaluation of a disk method for detection of hippurate hydrolysis by Campylobacter spp. J Clin Microbiol 1989; 27: 359-360
  9. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200- 209
  10. Sasmazel A, Baysal A, Fedakar A, Bugra O, Ozkokeli M, Buyukbayrak F, Keles C, Göçer S, Sunar H, Zeybek R. Treatment of brucella endocarditis: 15 years of clinical and surgical experience. Ann Thorac Surg 2010; 89: 1432-1436
  11. Inan MB, Eyileten ZB, Ozcinar E, Yazicioglu L, Sirlak M, Eryilmaz S, Akar R, Uysalel A, Tasoz R, Tuncay Eren N et al. Native valve brucella endocarditis. Clin Cardiol 2010; 33: E20- 26
  12. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-99
  13. Ulu-Kilic A, Metan G, Alp E. Clinical pres